Abstract
This chapter extends the principles of failure modes and effects analysis (FMEA) introduced in Chap. 2 with medical case examples. This chapter explores inductive reasoning or “forwards thinking” in the context of neurological diagnosis and treatment. FMEA facilitates understanding of symptoms from disease along physiological lines and helps predict effects on diverse organ systems. This facilitates treatment planning and implementing mitigation strategies in cases where the underlying disease itself is not directly treatable. It provides a framework to understand symptoms from a systems failure perspective, thereby optimizing the treatment response and preventing over- and undertreatment. FMEA also helps understand and implement strategies to anticipate, monitor, and mitigate side effects of many treatment regimens.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
SAE. ARP “4761”: guidelines and methods for conducting the safety assessment process on civil airborne systems and equipment, vol. 12; 1996.
Roberts NH, Vesely WE, Haasl DF, Goldberg FF. Fault tree handbook. NUREG-0492. Washington, DC: US Nuclear Regulatory Commission; 1981.
Vesley W, Dugan J, Fragole J, Minarik II J, Railsback J. Fault tree handbook with aerospace applications. Washington, DC: NASA Office of Safety and Mission Assurance, NASA Headquarters; 2002. 20546.
Traverse P. System safety in a few nutshells. In: ERTS Embedded Real Time Software 2008, Toulouse, France. 2008.
Machrouh J, Blanquart J-P, Baufreton P, Boulanger J-L, Delseny H, Gassino J, Ladier G, et al. Cross domain comparison of system assurance. In: ERTS-2012, Toulouse. 2012. p. 1–3.
Blanquart J-P, Astruc J-M, Baufreton P, Boulanger J-L, Delseny H, Gassino J, Ladier G, et al. Criticality categories across safety standards in different domains. In: ERTS-2012, Toulouse. 2012. p. 1–3.
Ledinot E, Astruc J-M, Blanquart J-P, Baufreton P, Boulanger J-L, Delseny H, Gassino J, et al. A cross-domain comparison of software development assurance standards. In: Proceedings of ERTS2. 2012.
Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8(5):475–90.
Brannagan TH. Current treatments of chronic immune‐mediated demyelinating polyneuropathies. Muscle Nerve. 2009;39(5):563–78.
Tracy JA, Engelstad JK, Dyck PJ. Microvasculitis in diabetic lumbosacral radiculoplexus neuropathy. J Clin Neuromuscul Dis. 2009;11(1):44.
Thaisetthawatkul P, Dyck PJ. Treatment of diabetic and nondiabetic lumbosacral radiculoplexus neuropathy. Curr Treat Options Neurol. 2010;12(2):95–9.
Fang JY. Update on the medical management of Parkinson’s disease. Continuum Lifelong Learning Neurol. 2010;16(1):96–109.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Balakrishnan, N. (2015). Failure Modes and Effects Analysis. In: Dependability in Medicine and Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-14968-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-14968-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14967-7
Online ISBN: 978-3-319-14968-4
eBook Packages: MedicineMedicine (R0)